Unraveling the multiple mysteries of ocular perfusion pressure in open angle glaucoma

Article

Evidence is mounting that ocular perfusion pressure - arterial pressure minus intraocular pressure - is an important risk factor for open-angle glaucoma.

Atlanta-Evidence is mounting that ocular perfusion pressure (OPP)-arterial pressure minus intraocular pressure (IOP)-is an important risk factor for open-angle glaucoma. However, this growing consensus still leaves several questions, such as how reliabile are OPP measurements, and how do you translate findings from epidemiologic studies into the clinical practice.

"Is taking blood pressure important in the diagnosis and management of glaucoma?" Dr.Marrelli asked. "I'm going to come down on the side that yes, it is important, although it's a little complex."

Vascular risk factors such as blood pressure and OPP may be more important than previously thought, because therapeutic intervention can alter their course, Dr. Marrelli said.

Autoregulation enables the eye to maintain a relatively constant blood flow over a fairly wide range of OPP, she explained. When OPP is either very high or very low, however, autoregulation may fail and the blood flow may not be consistent. When this occurs, the risk of developing glaucoma increases.

"Numerous studies over many different populations-in North America, in the Caribbean, in Europe, in Africa-have found that low diastolic OPP (less than 50-55mm Hg) has been associated with glaucoma as well as with glaucoma progression," Dr. Marrelli said.

Dippers big and little

She added, however, that interpretating this data is complicated. Reliable clinical measures of optic nerve head perfusion have been elusive, and using systemic blood pressure as a surrogate does not always accurately represent blood pressure in the ophthalmic artery.

Nocturnal blood pressure changes also complicate the picture, Dr. Marrelli said. Most people have a small but measurable (10% to 15%) drop in overnight blood pressure ("physiological dippers"), and a few have minimal or no change ("non-dippers"). A small group have a greater than 20% drop in overnight blood pressure ("extreme dippers").

If an extreme dipper's exceptionally low overnight blood pressure coincides with a peak IOP, OPP could drop to a level that places the individual at risk for development or progression of glaucoma, Dr. Marrelli said.

What does it mean?

Despite some variability, one predominant finding in glaucoma studies is that extreme dippers have a higher incidence of glaucoma and a higher risk of progression. Some studies have even shown that significant nocturnal fluctuation in blood pressure also may be a risk factor for glaucoma, she noted.

Determining what to do with these findings is problematic, Dr. Marrelli said. "We have pretty good evidence that low OPP and low blood pressure may be risk factors for glaucoma and glaucoma progression," she said.

"But what we don't have is evidence that if we raise the blood pressure, we will have any affect on the disease process, or even if we change OPP by doing things other than changing the IOP that we will change the course of the disease."

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.